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Abstract: Crop contamination by aflatoxin B1 is a current problem in tropical and subtropical 
regions. In the future, this contamination risk may be expanded to European countries due to climate 
change. The development of alternative strategies to prevent mycotoxin contamination that further 
contribute to the substitution of phytopharmaceutical products are thus needed. For this, a promising 
method resides in the use of biocontrol agents. Several actinobacteria strains have demonstrated 
to effectively reduce the aflatoxin B1 concentration. Nevertheless, the molecular mechanism of 
action by which these biological agents reduce the mycotoxin concentration has not been determined. 
The aim of the present study was to test the potential use of Streptomyces roseolus as a biocontrol 
agent against aflatoxin B1 contamination. Co-cultures with Aspergillus flavus were conducted, 
and the molecular fungal response was investigated through analyzing the q-PCR expression of 
65 genes encoding relevant fungal functions. Moreover, kojic and cyclopiazonic acid concentrations, 
as well as morphological fungal changes were also analyzed. The results demonstrated that reduced 
concentrations of aflatoxin B1 and kojic acid were respectively correlated with the down-regulation 
of the aflatoxin B1 gene cluster and kojR gene expression. Moreover, a fungal hypersporulated 
phenotype and a general over�xpression of genes involved in fungal development were observed in 
the co-culture condition. 
Keywords: Aspergillus flavus; Streptomyces roseolus; biocontrol; aflatoxin B1; gene expression; 
fungal morphology 
Key Contribution: The actinobacterial strain S. roseolus could decrease aflatoxin B1 (AFB1) produced 
by A. fl.avus acting on the AFB1 gene cluster. Moreover, inhibition of the AFB1 gene dus ter goes with 
a general up-regulation of developmental fungal genes. S. roseolus represents an alternative strategy 
to phytopharmaceutical products to reduce aflatoxin B1 contamination. 
1. Introduction
Aspergi1lus flavus is an opportunist soil pathogen fungus that is implicated in contamination
issues in the agriculture field and causes important economic losses [1]. This species is commonly 
found in crops such as maize, soybean, as well as oilseed, peanuts, dried fruits, and spices. A. flavus
produces a large number of secondary metabolites including several mycotoxins which impact the 
food sanitary quality. In this context, aflatoxin B1 (AFB1) is recognized as the most potent naturally 
occurring carcinogenic agent [2]. Indeed, AFB1 has been demonstrated to induce liver cancer and 
immunotoxic effects in humans and animals as well as growth impairment in children [3,4]. Due to the
physiological properties of A. flavus, AFB1 contamination is mostly found in tropical and subtropical
regions. However, due to climate change, the geographical distribution of AFB1 contamination may
increase in future years, leading to the occurrence of this mycotoxin in areas considered safe until
now [5,6]. Contamination by aflatoxins frequently occurs with cyclopiazonic acid (CPA), another
mycotoxin commonly produced by A. flavus strains that was demonstrated to be a cytotoxic agent in
humans [7,8]. Aspergillus section Flavi species are also able to synthesize non-toxinogenic secondary
metabolites, such as kojic acid (KA), a metabolite of interest for diverse industries. For example,
KA is employed as an inhibitor of pigment formation in plant and animal tissues in order to preserve
or change a substance’s color [9]. Currently, the use of phytopharmaceutical products is the most
frequent strategy to limit mycotoxin contamination. However, the massive use of such products has led
to the accumulation of toxic chemical residues in agricultural products as well as in water and soil [10].
This observation led researchers to develop alternative strategies such as the use of biocontrol agents.
In fact, certain microorganisms have demonstrated the ability to reduce mycotoxin concentrations while
maintaining an ecological niche balance [11,12]. Concerning AFB1 biocontrol, one of the best-known
strategies is the use of non-aflatoxigenic A. flavus strains, like Afla-guard® (Circle One Global, Inc.,
Shellman, GA, USA) or Aflasafe® (IITA, Ibandan, Nigeria). However, it has been demonstrated that
recombination phenomena between non-aflatoxigenic and aflatoxigenic A. flavus strains can occur,
decreasing the effectiveness of this method [13,14]. In parallel, bacterial strains belonging to the Bacillus,
Pseudomonas, Agrobacterium and Streptomyces genera have also been demonstrated to limit mycotoxin
concentrations [15–18]. Within this group, Streptomyces spp are ubiquitous soil bacteria that are able to
produce endospores and bioactive compounds with a broad spectrum, including anti-aflatoxinogenic
properties. Recent studies have demonstrated that several actinobacteria strains greatly reduce the
AFB1 concentration without affecting fungal growth [19,20]. Nonetheless, the specific molecular
mechanism of action by which these microorganisms act remains to be determined. Therefore,
the present work aimed to test the potential use of S. roseolus as a biocontrol agent against AFB1
contamination using the co-culture method with A. flavus. For this, analyses of fungal secondary
metabolite concentrations (AFB1, CPA, and KA), fungal gene expressions, and morphological changes
were performed. A total of 65 genes were analyzed: 29 genes involved in AFB1, CPA, and KA
biosynthesis and 36 genes coding for diverse regulatory factors linked to fungal processes such as
cellular signaling, development regulation, global transcription factors as well as genes involved
in environmental and oxidative stress responses. The results demonstrated that under co-culture
conditions, the AFB1 concentration was reduced to undetectable levels and almost all genes belonging
to the AFB1 cluster were down-regulated. The KA concentration was reduced by 37% under the
co-culture condition, and the expression of the specific transcription factor kojR, which is involved in
KA biosynthesis, was down-regulated. The CPA concentration was not modified and the expression
of the dmaT gene involved in its biosynthesis was up-regulated. Concerning fungal development,
a hypersporulation phenotype was observed in A. flavus. Moreover, a general over-expression of genes
involved in the regulation of fungal development was observed.
2. Results
2.1. Production of Secondary Metabolites in A. flavus
AFB1, KA, and CPA concentrations were quantified in both culture conditions. The co-culture
condition induced a significant reduction in the concentration of AFB1 to undetectable levels in
comparison with the control (972.8 µg/L ± 254.9 µg/L, p-value < 0.0001). In the co-culture
condition, the HPLC analysis demonstrated a reduction in the KA concentration of 37%
(1.29 mg/mL ± 0.22 mg/mL for control vs 0.81 mg/mL ± 0.29 mg/mL for co-culture conditions,
p-value = 0.2159). Finally, the CPA concentration was slightly, but not significantly, reduced
(0.79 mg/mL ± 0.08 mg/mL for the control culture vs 0.68 mg/mL ± 0.22 mg/mL for the co-culture,
p-value = 0.6835).
2.2. Morphological Changes
Morphological studies were performed by SEM observation and spore quantification. SEM images
demonstrated that A. flavus’ mycelium presented noticeable differences under co-culture condition.
A visual augmentation in spore quantity was observed in different areas and by several prints over the
aerial fungal mycelium (Figure 1a,b). Moreover, in the basal mycelium, aberrant spore development
all along the hyphae was observed in the co-culture condition (Figure 1c,d). In order to confirm
this phenomenon, spore quantification was performed demonstrating that the co-culture condition
induces a significant 36% increase in the spore quantity in A. flavus (9.4 × 106 ± 4.35 × 105 vs.
1.2 × 107 ± 3.63 × 105; p-value = 0.004).
              
              
       
                
                  
Figure 1. Morphological analysis of A. flavus by Scanning Electronic Microscopy. (a) Aerial mycelium in
control condition; (b) aerial mycelium in co-culture condition; (c) basal mycelium in control condition
and (d) basal mycelium in co-culture condition.
2.3. Expression Analysis of Genes Involved in Fungal Secondary Metabolite Pathways
The AFB1 biosynthetic pathway is governed by 27 genes grouped into a cluster regulated by
two specific transcriptional factors, aflR and aflS. In this study, the entire gene cluster was analyzed.
The results demonstrated that a 4-day co-culture with S. roseolus, induced a significant down-regulation
of all genes involved in AFB1 gene cluster in A.flavus with the only exception being aflT (p-value = 0.254)
(Figure 2). The gene expression of the two specific transcriptional factors, aflR and aflS, was decreased
by 6-fold. Kojic acid production is directed by a gene cluster governed by the specific transcriptional
factor encoded by kojR. The expression of the latter was significantly reduced by 2-fold in the co-culture
condition. Besides, the expression of the dimethylallyltryptophan synthase dmaT, involved in the CPA
biosynthetic pathway, was significantly up-regulated by 3.2-fold in the co-culture condition.
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Figure 2. Fold change in the expression of genes belonging to the aflatoxin 81 (AFBI), 
cyclopiazonic acid and kojic acid biosynthetic pathways. The dotted baseline represents the control 
expression level; ns = no significant change; " p-value < 0.05; "" p-value < 0.01; ,.,.,. p-value < 0.001. 
SM = secondary metabolite. 
2.4. Expression Analysis of Genes Involved in Fungal Development 
An expression analysis of several genes involved in fungal development, the velvet family, 
and global regulators was performed. As shown in Figure 3, a general over-expression of the 
analyzed genes was observed. For instance, genes involved in conidiation and conidiophore 
morphology, like abaA, brlA, flbA and fluG, increased by 1.7- to 2.8-fold. Concerning the velvet 
family, the results showed that veA, velB, and vosA presented significant increases of 1.8-, 2.1-, 
and 1.9-fold, respectively. Nevertheless, laeA expression was not impacted by the co-culture condition 
(p-value = 0.710). Among the global regulators analyzed in this study, the transcription factor mtfA 
was the most affected gene with an up-regulation of 3.5-fold. Small but significant changes were also 
observed for nsdC expression, another transcription factor required for conidiophore development 
with an up-regulation of 1.7-fold. 
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Figure 3. Analysis of the expression of genes linked to the conidiation process, the velvet protein 
complex, and global regulators. The dotted baseline represents control expression level; ns = no 
significant change; " p-value < 0.05; "" p-value < 0.01; ,.,.,. p-value < 0.001. 
2.5. Expression Analysis of Genes Involved in Fungal Response ta External Stimuli 
In fungi, extemal changes trigger the rapid activation of environmental and cellular signaling 
transduction in order to ensure fungal adaptation. Thus, the expression of several genes involved in 
this process were analyz.ed. The results presented in Figure 4 demonstrate that the co-culture condition 
induced an up-regulation of the expression of creA and meaB genes by 2.5- and 1.6-fold, respectively. 
Among the GPCR genes, gprK, the principal regulator of the G-protein signaling presented a reduced 
expression by 2-fold. Despite the gprK down-regulation, the other gpcr genes were significantly 
up-regulated, gprA being the most impacted gene with an increased level by 5.5-fold. The expression 
of gprG as well as fadA, which encodes the subunit G-protein, did not present significant differenœs 
(p-values = 0.132 and 0.710). Finally, within dioxygenase oxylipins' gene group, ppoA was marginally 
down-regulated (fold expression of 0.7) while ppoB and ppoC were up-regulated by 3.2-fold. 
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Figure 4. Fold change expression of genes involved in environmental responses and cellular 
signalization. The dotted baseline represents the conbol expression level; ns no significant change; 
,. p-value < 0.05; ,.,. p-value < 0.01;"'"• p-value < 0.001. 
2.6. Expression Analysis of Genes Inoolved in Fungal Oxidative Stress Response 
The response to oxidative stress is a fungal defense mechanism Jinked to secondary metabolite 
production and involves several transcription factors. Among them, the expression of 10 genes was 
analyzed. As shown in Figure 5, the expression levels of seven genes were significantly modified upon 
c:<rculture condition. 1he two most impacted genes were the bZIP transcription factor atfB which was 
dramatically down-regulated by 149.2-fold and the cat2 gene, which codes for a bifunctional catalase 
peroxidase and was up-regulated by 3.7-fold. Among the other analyzed genes, catA, which encodes a 
development regulating catalase, and sakA and ssfcA, which are involved in the MAPK and SakA /HogA 
stress signaling pathways, were down-regulated by 2.2-, 4.5-, and 13-fold respectively. Conversely, 
the manganese superoxide dismutase mnSOD was up-regulated by V~fold. Otherwise, no significant 
changes were observed for the rest of the analyzed genes (p-values = 0.210-sodl; 0.756-apl; 0.59>msnA; 
0.172-srrA, and 0.314-pkaA). 
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Figure 5. Fold change expression of genes invotved in the oxidative stress response. The dotted baseline 
represents control expression level; ns = no significant change; ,. p-value < 0.05; .. p-value < 0.01; 
,.,.,. p-value < 0.001. 
3. Discussion 
The contamination of foodstuffs by fungal development has many negative consequences such 
as the alteration of commodities, the loss of nutritional qua]ities, a strong reduction in production 
yields, and the accumulation of toxic compounds such as mycotoxins. For example, AFB1, produced
by A. flavus, is the most potent naturally occurring carcinogen known to contaminate foodstuffs.
Faced with mycotoxin contamination issues, the use of phytopharmaceutical products was favored for
several years. However, consumers are increasingly paying attention to the consequences of using
such chemical products in agriculture. Thus, environmental-friendly alternative methods should
be developed. Within this context, in the present study, S. roseolus was used as biocontrol agent to
reduce AFB1 contamination by A. flavus and the molecular mechanism of action was elucidated by
transcriptomic analysis.
3.1. Effects of S. roseolus on AFB1 Concentration and Gene Expression of AFB1 Cluster Genes
Previous studies have demonstrated that the co-culture of S. roseolus and A. flavus induces a
significant reduction int the AFB1 concentration until no detectable level is present, with a slight
effect on the growth of A. flavus [20]. In the present study, the reduction in the AFB1 concentration
was the result of the down-regulation of all but one of the genes (aflT) in aflatoxin’s gene cluster.
The AFB1 cluster is internally regulated by the specific transcriptional factors encoded by aflR
and its coactivator, aflS. The interaction between the corresponding proteins is required for the
formation of an active complex that triggers AFB1 production [21]. As demonstrated, the co-culture
condition reduced the concentration of the AflR/AflS complex, leading to the down-regulation of
AFB1 cluster activation and consequently, to a lower concentration. A transcriptional analysis of the
AFB1 gene cluster in the co-culture condition demonstrated that genes involved early on in the AFB1
enzymatic cascade (i.e., aflA, aflB, aflC) that participate in the construction of the first stable polyketide
structure, norsolorinic acid, were less impacted compared to those coding for enzymes involved
at the intermediate and latter steps (i.e., aflK, aflM, aflO, aflP) [22]. This suggests that the reduced
concentration of the AflR/AflS complex might have been consumed at the beginning of the AFB1
biosynthesis pathway, interrupting it in the first enzymatic stages and further leading to a significant
reduction in the final AFB1 concentration. In accordance with this, similar results were obtained using
eugenol, a natural extract that reduces the AFB1 concentration in A. flavus cultures [23].
3.2. Effect of S. roseolus on the KA and CPA Concentrations
In this global transcriptomic analysis, the expressions of kojR and dmaT, which are, respectively,
involved in KA and CPA biosynthesis, were also analyzed. The down-regulation of kojR was correlated
to the decrease of KA concentration in the co-culture condition. These results confirm the report of
Marui et al. [24] who demonstrated that the kojR gene, encoding a Zn(II)2Cys6 transcriptional factor,
is essential for the activation of the KA cluster and thus, for KA production. In this study, the use of
S. roseolus simultaneously reduced the AFB1 and KA concentrations. On the contrary, other authors
observed a reduction in the AFB1 concentration with an increase in the KA concentration by using
D-glucal, C18:3 fractions, and dioctatin-A [25–27]. These results suggest the production of A. flavus
secondary metabolites depends on the used agent. The expression of the dmaT gene in A. flavus
was also analyzed. This gene, which encodes a dimethylallyltryptophan synthase, is involved in the
second step of the CPA biosynthetic pathway and leads to the formation of β-CPA [28]. In this study,
the amount of β-CPA was not quantified but the increase of only one intermediate is not enough to
lead to an increase in the concentration of the last compound of the biosynthetic pathway (i.e., CPA).
Indeed, biosynthetic pathways are complex and from a molecular point of view, all of the involved
enzymes operate at the same time in order to take over each intermediate just after their synthesis.
An increase in one intermediate does not increase the activity of the involved enzyme during its
conversion which might explain why the CPA concentration is the same in both culture conditions.
3.3. Morphological Changes in A. flavus in Co-Culture with S. roseolus
Under co-culture conditions, an increase in the spore amount was observed. This hypersporulated
phenotype can be partially correlated to a general over-expression of genes involved in the conidiation
process. Among them, the sequential expression of brlA and abaA plays an important role within the
conidiogenesis pathway [29]. BrlA encodes an early regulator of fungal development and its activation
is necessary and sufficient for conidiophore development [30–32]. BrlA also activates AbaA which plays
a central role in the differentiation of phialides during the middle stage of conidiophore development
after the differentiation of the metulae [33,34]. Therefore, in this study, higher transcription levels
of brlA were associated with the up-regulation of abaA and thus, with the subsequent activation of
fungal conidiation. These results are in agreement with those reported by Lv et al., where eugenol,
an AFB1 inhibitor, induced the increased transcription of brlA and abaA to activate fungal conidiation in
A. flavus [35]. Adam et al. also demonstrated that the over-expression of brlA in vegetative cells leads to
the initiation of cellular transformations resembling those occurring during conidiophore development
and conidia production [30]. BrlA expression is also linked to the flb genes (e.g., fluG, flbA-flbE) which
are individually required for the normal programed switch from hyphae growth to conidiophore
development [36]. Specifically, fluG is required for an early step in the activation of the sporulation
pathway involving the synthesis of an extracellular sporulation inducing factor (ESIF) which is an
activator key of conidiation [37]. In co-culture condition, an up-regulation of fluG and flbA expression
levels was observed. These results are in agreement with those reported by Lee and Adams [38] where
the over-expression of fluG and flbA resulted in the over-expression of brlA, inducing the formation
of conidiophores and allowing sporulation in submerged cultures. The other genes participating in
the morphological process analyzed in this study, veA, velB, vosA (belonging to the velvet family),
mtfA, and nsdC (global regulators) were also significantly up-regulated. These genes have also been
demonstrated to participate in secondary metabolite production in Aspergilli species [39–42]. Indeed,
in this study, differential expressions of these developmental regulators induced significant changes in
A. flavus morphology that were accompanied by decreased concentrations of AFB1 and KA. Another
study performed with a natural AFB1 inhibitor Micromeria graeca in A. flavus, also resulted in increased
transcription levels of veA, mtfA, and nsdC [12]. Interestingly, morphological aberrances were also
observed, for example, phialide formation along the fungal hyphae with an increase of spore quantity.
Taken together, these results suggest that the up-regulation of the genes involved in the morphological
process induced the hypersporulated phenotype of A. flavus in the co-culture with S. roseolus.
3.4. Impact of S. roseolus on Fungal Cellular Signalization and the Oxidative Stress Response
In fungi, environmental changes activate signaling pathways as a mechanism of adaptation.
Under the co-culture condition, creA, a gene encoding a carbon repression regulator,
was over-expressed. CreA has also been involved in aflatoxin biosynthesis since several AFB1 genes
possess CreA sites near to their promoter regions [43]. In fact, a recent study reported that creA is
highly involved in the mechanism of AFB1 inhibition by gallic acid in A. flavus [44]. Regarding the
other genes involved in cellular signalization, those belonging to the GPCR transmembrane receptors
(gpr genes), oxylipins dioxygenases (ppo genes) and a member of the RAS family (rasA) were impacted
in S. roseolus co-culture. Thus, it has been demonstrated that GPCR members are involved in the
oxylipin response and that a proper regulation of the G-protein signalization plays a central role
during the activation of signal transduction to surrounding changes as well as regulating secondary
metabolite production [45–47]. Hence, the presented results suggest that the observed changes in the
transcriptional expression levels of the gpr, ppo, and ras genes resulted in a disturbed signal transduction
of the G-protein pathway and may negatively impact AFB1 biosynthesis. Indeed, among the several
GPCRs that were analyzed. GprA and gprP genes were over-expressed and both were demonstrated as
aflatoxin repressors in A. flavus [45]. RasA expression was also increased and may also be correlated
with AFB1 reduction since the activation of this GTP-binding protein has been negatively associated
with sterigmatocystin production through aflR repression in A. nidulans [48]. Finally, among the genes
involved in the oxidative stress response, atfB was the most impacted gene. The down-regulation of
this bZIP transcription factor can be associated with both the decreased levels of secondary metabolites
and to the stress response. On one hand, due to the fact that AtfB possesses binding sites in the
promoters of seven aflatoxin genes [49], its dramatic down-regulation might be hardly implicated in
the molecular mechanism leading to AFB1 reduction induced by S. roseolus. On the other hand, atfB is
essentially required for catA expression [50]; thus, in this study, the decreased levels of atfB induced
the down-regulation of catA, which is involved in conidia stress. Since catA disruption in A. nidulans
produced spores that are sensitive to stress agents such as H2O2 [51], further studies to evaluate the
spore resistance of A. flavus under co-culture conditions will be of interest.
4. Conclusions
As an alternative to phytopharmaceutical products in the agricultural field, this study provides a
proof of concept using biocontrol agents to reduce mycotoxin contamination. S. roseolus was used as
a biocontrol agent to reduce the aflatoxin B1 concentration in A. flavus using the co-culture method.
Several approaches, such as transcriptomic and morphological studies, were performed to elucidate
its molecular mechanism of action. Under the co-culture condition, the main result was the reduction
of the aflatoxin B1 concentration to undetectable levels. A transcriptomic analysis revealed that the
aflatoxin B1 biosynthetic pathway was interrupted at an early stage before the norsolorinic acid
synthesis—at the first toxic AFB1 precursor. The main morphological change in A. flavus was the
expression of a hypersporulated phenotype accompanied by spore formation directly on fungal hyphae.
Taken together, these promising results provide the proof of concept that S. roseolus represents an
alternative strategy to aflatoxin B1, the most highly carcinogenic and mutagenic fungal contaminant.
5. Materials and Methods
5.1. Chemicals and Reagents
Aflatoxin B1 (AF B1), cyclopiazonic acid (CPA) and kojic acid (KA) standards were purchased
from Sigma-Aldrich (Saint-Quentin-Fallavier, France). Stock solutions were respectively prepared in
methanol, ethanol, and water and stored at −18 ◦C until use. Solvents used for secondary metabolites
extraction and High-Performance Liquid Chromatography (HPLC) were of analytical grade quality
and were purchased from Thermo-Fisher Scientific (Illkirch, France). The ultrapure water used for
HPLC and for the molecular biology procedures was purified at 0.22 µm by an ELGA purification
system (ELGA LabWater, High Wycombe, UK).
5.2. Strains
The Streptomyces roseolus strain used in this study was previously identified [52] and selected
for its capacity to reduce the AFB1 concentration with a slight reduction in A. flavus growth [20] and
was maintained on solid ISP2 medium (4 g/L α-D glucose; 10 g/L malt extract; 4 g/L yeast extract;
20 g/L agar). The referenced toxinogenic Aspergillus flavus NRRL 62477, producer of AFB1, CPA,
and KA was isolated from paprika samples harvested from a Moroccan market [53]. Stock cultures of
A. flavus were maintained on solid Czapek Yeast Extract Agar medium (CYA) (30 g/L sucrose; 5 g/L
yeast extract; 15 g/L agar; metal solution).
5.3. Culture Conditions
Firstly, the interaction between both strains, A. flavus and S. roseolus, was performed according
to the co-culture method previously described by Sultan and Magan [54] and modified by
El Khoury et al. [18]. A cellophane disk (Hutchinson, Chalette-sur-Loing, France) was layered on
solid ISP2 medium before the inoculation of strains to allow the separation of mycelium from the
culture medium, as previously described by Leite et al. [55]. Then, ten microliters of A. flavus calibrated
spore suspension (106 spores/mL at 0.05% Tween 80) prepared from a seven-day culture was used
to centrally inoculate the solid ISP2 medium. Then, S. roseolus mycelium was directly retrieved from
a seven-day culture with a sterile steak and was co-inoculated on both sides of the fungal inoculum
spot by tracing parallel lines separated from 2 cm from the Petri dish edge. For the control condition,
A. flavus cultures were inoculated alone. Control and co-culture conditions were conducted in Petri
dishes filled with 20 mL of ISP2 medium, and cultures were incubated at 30 ◦C for four days at a relative
humidity of 80% in a Vötsch chamber (Illkirch, France). At the end of the incubation period, on one
side, mycelium was separated from the medium by a peel-off cellophane disk and then, quickly frozen
and stored at −80 ◦C until RNA extraction for transcriptomic analysis. One the other side, the medium
was collected to perform fungal secondary metabolites extraction, as described below.
5.4. Secondary Metabolite Extraction and Quantification by UHPLC/FLD/DAD
Fungal secondary metabolites were extracted from the entire medium using 25 mL of chloroform
and left to macerate for 1 h on a horizontal shaking table set at 200 rpm at room temperature.
Extracts were then filtered through a Whatman 1PS phase separator (GE Healthcare Life Sciences,
Vélizy-Villacoublay, France) and the organic phase was recovered and evaporated until dryness under
a rotavapor set at 60 ◦C. Samples were resuspended with 500 µL of a water–acetonitrile–methanol
mixture (65:17.5:17.5; v/v/v) and filtered through 0.45 µm PTFE disk filters (Thermo Scientific Fisher,
Villebon-Sur-Yvette, France). The detection of fungal secondary metabolites was performed using a
Dionex Ultimate 3000 UHPLC system coupled with a Diode-Array Detector (DAD) and a Fluorescent
Detector (FLD) (Thermo Fisher Scientific, Illkirch, France). AFB1 was detected using the FLD with
365/440 nm excitation/emission wavelengths, and the UV spectrum was further confirmed by the
DAD. CPA and KA were detected using the DAD, which was set at 285 and 265 nm respectively.
Analyses of AFB1 and KA were performed using a Luna C18 column (3 µm, 200 × 4.6 mm)
(Phenomenex, Torrance, CA, USA). A 50 min isocratic mode was delivered with 65% of Eluent A
(0.2% acetic acid/water and acetonitrile: 79:21 v/v) and 35% of Eluent B (pure methanol). For the CPA
analyses, a Luna C18 column was used (3 µm, 150 mm × 2.0 mm, Phenomenex, Torrance, CA, USA).
Eluent A consisted of acidified water (0.1% of formic acid) and Eluent B was pure acetonitrile. The
following gradient elution program was as follows: 40% B for the first ten minutes, then the percentage
of eluent B increased up to 90% within five minutes and remained at this value for ten minutes. Then,
the initial conditions were restored within five minutes and remained constant for ten minutes. All the
analyses were performed with a flow rate delivered at 0.2 mL/min, a column temperature controlled
at 30 ◦C and an injection volume of 20 µL. The peak identity of each secondary metabolite was
confirmed by comparing the UV spectrum and the retention time (min) with the commercial standards
(Sigma-Aldrich, Saint-Quentin-Fallavier, France). Quantification of each secondary metabolite was
assessed with a standard curve. The limits of quantification (LOQ) were 100 µg/L for AFB1, 0.05 mg/L
for KA, and 90 mg/L for CPA. The limits of detection (LOD) were 30 µg/L for AFB1, 0.01 mg/L for
KA, and 20 mg/L for CPA.
5.5. Fungal RNA Extraction and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
For the gene expression analysis, RNA was extracted from the collected mycelia which were
finely ground under liquid nitrogen. Purification of RNA was performed using the Qiagen RNeasy
PlusMinikit (Qiagen, Hilden, Germany) in accordance with the manufacturer’s recommendations.
RNA concentrations were quantified using a Nanodrop 2000 spectrophotometer (Thermo Scientific,
Illkirch, France) RNA integrity and purity were checked using the Experion RNA analysis kit and
software (version 3.20, 2015, BioRad, Marnes-la-Coquette, France). First-strand cDNA synthesis
was carried out with an Advantage RT-PCR kit (Clontech, Saint-Quentin-en-Yvelines, France).
In accordance with the manufacturer’s instructions, 1 µg of total RNA was synthesized using an
oligo dT (5′-GCTGTCAACGATACGCTATAACGGCATGACAGTGTTTTTTTTTTTTTTT-3′).
5.6. Quantitative Polymerase Chain Reaction (q-PCR) Analysis
Q-PCR experiments were performed using a ViiA7 Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA). The choice of genes analyzed in this study was based on previous
works reported by Caceres et al. [23,56] and complementary sequences were added in
this study: kojR (F: ACACCGCGCTGGAGACTATAGA R: GTTGTTGAACCTTGTTCGGTCAG);
dmaT (F: GACTGGCCACCTTCTTTGAGC R: GCAGTATTTAAGTCCACATCCGGATAG) and pkaA
(F: GCTTCGCAAGTCTCAGCGAT R: ACTTCCGCGGCGTAGAACT). For this study, a total of 65 genes
were simultaneously analyzed and divided into 4 main categories: (I) 29 genes involved in secondary
metabolite biosynthesis, 27 specifically belonging to the AFB1 cluster and 2 involved in CPA and
KA biosynthesis (dmaT and kojR); (II) 11 genes related to fungal development, 4 genes linked to the
conidiation process (abaA, brlA, flbA, and fluG), 4 genes belonging to the velvet family (veA, velB, laeA,
and vosA), and 3 genes coding for global regulators (fcr3, mtfA, and nsdC); (III) 15 genes involved in
external stimuli responses including: 4 genes coding for environmental transcription factors (areA, creA,
meaB, and pacC) and 11 genes involved in cellular signaling, including G-Protein Coupled Receptors
(GPCRs) and sub-units (gprK, gprA, gprG, gprH, gprP, and fadA), 3 oxylipins (ppoA, ppoB, and ppoC),
a member of the RAS family (rasA), and a protein kinase A pkaA; and (IV) 10 genes involved in the
oxidative stress response: atfA, atfB, catA, cat2, sod1, mnSOD, ap-1, msnA, srrA, and sskA. For the
gene expression experiments, 384-well plates were prepared by an Agilent Bravo Automated Liquid
Handling Platform (Agilent Technologies, Santa Clara, CA, USA). The experimental mix consisted
of 1 µL of cDNA sample, 2.5 µL of Power SYBR® Green PCR Master Mix (Applied Biosystems,
Warrington, UK), and 1.5 µL of the corresponding primer set. Quantitative steps were performed as
previously reported by Caceres et al. [23].
5.7. Fungal Spore Quantification
The quantity of fungal spores was measured according to the method previously reported
by Caceres et al. [55]. Briefly, the entire A. flavus mycelium from each Petri dish was submerged
in 50 mL of a Tween 80 solution (0.05% v/v water) to collect fungal spores by scraping. Then,
the solution was filtered through sterile gauze and spores were counted using a Thoma cell chamber
(Olympus, Rungis, France). Spore quantities from A. flavus under control and co-culture conditions
were compared.
5.8. Microscopic Analysis
Morphological changes of A. flavus in co-culture with S. roseolus were characterized by Scanning
Electronic Microscope (SEM). Samples were directly withdrawn from the co-culture using double-faced
metallic adhesive tape. Amelioration of the image signal was achieved by coating samples with gold
for 60 s at 10−1 mbar using a Scancoat six apparatus (HHV Ltd., Crawley, UK). Electronic images were
obtained using a Hitachi TM3000 microscope (Hitachi, Tokyo, Japan), and spectra were recorded using
an acceleration voltage of 15 kV.
5.9. Statistical Analysis
Student’s t-tests followed by a Fischer test on the equality of variance were used to analyze
the differences between control and co-culture conditions. The statistical analysis of data was
carried out with GraphPad Prism 4 software (GraphPad Software, La Jolla, CA, USA). Differences
were considered to be statistically significant when the p-value was lower than 0.05. For fungal
gene expression, experiments were repeated twice using six biological samples for each condition.
Otherwise, three samples per condition were used. Graphical values are represented by mean ±
standard error of mean (SEM).
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